<DOC>
	<DOCNO>NCT00153114</DOCNO>
	<brief_summary>Assess safety efficacy polyethyleneglycol3350 laxative compare placebo therapy pediatric patient history constipation .</brief_summary>
	<brief_title>PolyethyleneGlycol3350 Laxative v Placebo Constipated Children</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>Male female outpatient age 4 16 year . Adolescent female patient must pregnant lactating . constipate accord ROME I definition Two few bowel movement initial observation week . Absence stool impaction Bowel movement receive enema Are otherwise good health , judge physical examination . Parent guardian mentally competent sign instrument inform consent Patients heme positive stool baseline exam . Patients fecal impaction baseline , observation period , indicate physical exam Patients know suspected perforation obstruction fecal impaction . Patients breastfeed , pregnant intend become pregnant study . Female patient childbearing potential refuse pregnancy test . Patients known history organic cause constipation . Patients congenital malformation produce constipation ( Hirschsprung 's disease , imperforate anus , child cerebral palsy neurologic abnormality , systemic disease ) . History gastric retention , inflammatory bowel disease , bowel resection , colostomy . Use concomitant medication cause constipation Patients , opinion investigator , include study reason , include inability follow study procedure . Patients know allergy polyethyleneglycol polyethyleneglycol contain medication . Patients clinically significant elevation TSH abnormal plasma electrolyte . Patients , within past 30 day participate investigational clinical study</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>